Today, SwedenBIO, the national non-profit association for the life science industry in Sweden, LIF, the trade association for the research-based pharmaceutical industry in Sweden, and Swedish Medtech, the association for Medical Technology in Sweden, have presented a common action plan for life science.
The action plan highlights three important areas which has to be strengthened in order for companies to operate and develop in Sweden. These are research and development, the introduction of innovative treatment methods and Sweden being the first choice at investments and establishments.
The organizations then propose 19 actions. They state that a clear effort on life science requires commitement from several actors. In 2015 the government appointed a life science coordinator and in February, the government established a life science office which will present an agenda and strategy this year. But it is only when decisions and efforts become actions that we can see real and effective results, they say.
In addition to the new life science office, authorities, the head of universities, county councils, municipalities and companies must understand their part of the plan, participate and carry through the changes that are necessary in order for us to maintain and develop a vigorous industry, the organizations states in a press release.
Photo of Anna Lefevre Skjöldebrand, CEO Swedish Medtech, Anders Blanck, CEO LIF (Photo: Gunilla Lundström), and Jonas Ekstrand, CEO SwedenBIO (Photo Mikael Wallerstedt)
